• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novelix Pharmaceuticals Ltd Trading

  • Indian Private
  • BSE Code : 33252.0
  • ISIN : INE314I01036
70.00 0 (-0.07%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    64.35

  • Today’s High

    75.00

  • Open

    75.00

  • Perv Close

    70.05

  • 52W Low

    38.00

  • 52W High

    92.00

Key Indicators

  • P/E(TTM)

    55.12

  • Mar.Cap (₹Cr.)

    199.29

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.08

  • Debt-Equity Ratio

    -0.07

  • AGM Date

    30-Sep-2026

  • EPS

    1.27

  • P/E Ratio

    55.12

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    199.29

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.47

  • BV (₹)

    23.10

  • Sales( ₹ in Cr.)

    132.31

  • NP (in Cr.)

    2.56

  • NP Var(%)

    2926.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    199.29

  • 52 Week High

    92.00

  • 52 Week Low

    38.00

  • Price BSE

    70.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    199.29

  • P/C Ratio

    75.00

  • P/E Ratio

    78.00

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 132.31 30.72 4.22 1.92 1.14 1.31
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 132.31 30.72 4.22 1.92 1.14 1.31
Other Income 0.03 0.02 0.31 0.00 0.25 0.00
Stock Adjustments 13.59 -0.35 0.37 0.29 0.28 -0.14
Total Income 145.93 30.39 4.90 2.21 1.67 1.17
EXPENDITURE :            
Raw Materials 140.30 29.22 4.21 1.64 1.09 0.88
Power and Fuel Cost 0.07 0.03 0.01 0.01 0.01 0.01
Employee Cost 0.71 0.07 0.13 0.16 0.14 0.15
Other Manufacturing Expenses 0.15 0.02 0.01 0.02 0.02 0.03
Selling and Administration Expenses 1.12 0.56 0.35 0.36 0.38 0.31
Miscellaneous Expenses 0.01 0.32 0.14 0.01 1.53 2.98
Employee Benefit Expenses 0.71 0.07 0.13 0.16 0.14 0.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 142.35 30.22 4.84 2.21 3.17 4.36
Operating Profit 3.58 0.16 0.06 0.00 -1.49 -3.19
Interest 0.07 0.00 0.00 0.00 0.00 0.00
Gross Profit 3.51 0.16 0.06 0.00 -1.49 -3.19
Depreciation 0.10 0.04 0.04 0.06 0.07 0.08
Profit Before Tax 3.41 0.12 0.02 -0.06 -1.56 -3.27
Current Tax 0.83 0.03 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 0.01 0.01 0.00 -0.01 0.00
Reported Net Profit 2.56 0.08 0.01 -0.06 -1.56 -3.27
Extraordinary Items 0.00 0.00 0.00 0.00 -0.02 0.00
Adjusted Net Profit 2.56 0.08 0.01 -0.06 -1.54 -3.27
Adjustment below Net Profit 0.00 0.00 -0.01 0.01 0.00 0.00
P & L Balance brought forward -1.88 -1.96 -1.96 -2.37 -0.81 2.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.01 0.00 0.07
P & L Balance carried down 0.68 -1.88 -1.96 -2.43 -2.37 -0.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.21 0.08 0.01 -0.07 -1.93 -4.04
Earnings Per Share(Adj)-Unit Curr 1.21 0.08 0.01 -0.07 -1.93 -4.04
Book Value 22.05 17.63 9.08 8.88 8.94 10.87
Book Value(Adj)-Unit Curr 22.05 17.63 9.08 8.88 8.94 10.87

Shareholding Pattern

  • Promoter Group

    54.29%

  • Public Share Holding

    45.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,002,000 35.13 10,002,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,455,733 19.16 5,455,733 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,457,733 54.29 15,457,733 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 670,151 2.35 662,051 21
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 234,711 0.82 234,711 11
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 44,724 0.16 44,724 42
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,452,533 36.71 10,419,133 84
Individuals holding nominal share capital up to Rs. 1 lakh 1,469,701 5.16 1,187,391 2,958
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 125,900 0.44 125,900 1
Sub Total 13,012,267 45.71 12,688,457 3,119
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,470,000 100.00 28,146,190 3,127

Company Background

Novelix Pharmaceuticals LtdTrading

  • Novelix Pharmaceuticals Ltd
  • BSE Code : 33252.0
  • ISIN : INE314I01036

  • Incorporation Year

    1994

  • Registered Office

    4-4-231/1/2/ABC Inderbagh
    Sultan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-24757370

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Nishita Kalantri

  • Auditor

    CVS Bala Chandra Rao & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Novelix Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novelix Pharma. 70.00 132.34 132.31 55.12 10.56
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77